Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label was standardized from 'Intervention / Treatment' to 'Intervention/Treatment'. A recruitment status note 'No longer looking for participants' appears, and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check17 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a platform/software update for the page. This change signals an underlying update rather than any modification to the study details or results.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now shows a new revision label, v3.5.4, replacing the previous v3.5.3. This indicates an update to the page’s versioning metadata.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3 without changing the displayed study details.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check82 days agoChange DetectedThe Italian site entry changes from Padua to Padova (35128).SummaryDifference0.0%

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.